Cargando…

Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches

As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyunho, Kim, Eunyoung, Lee, Ingoo, Bae, Bongsung, Park, Minsu, Nam, Hojung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Biotechnology and Bioengineering 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790479/
https://www.ncbi.nlm.nih.gov/pubmed/33437151
http://dx.doi.org/10.1007/s12257-020-0049-y
_version_ 1783633433616973824
author Kim, Hyunho
Kim, Eunyoung
Lee, Ingoo
Bae, Bongsung
Park, Minsu
Nam, Hojung
author_facet Kim, Hyunho
Kim, Eunyoung
Lee, Ingoo
Bae, Bongsung
Park, Minsu
Nam, Hojung
author_sort Kim, Hyunho
collection PubMed
description As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Generally, AI is applied to fields with sufficient data such as computer vision and natural language processing, but there are many efforts to revolutionize the existing drug discovery process by applying AI. This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning. The main data sources in each field are also summarized in this review. In addition, an in-depth analysis of the remaining challenges and limitations will be provided, and proposals for promising future directions in each of the aforementioned areas.
format Online
Article
Text
id pubmed-7790479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society for Biotechnology and Bioengineering
record_format MEDLINE/PubMed
spelling pubmed-77904792021-01-08 Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches Kim, Hyunho Kim, Eunyoung Lee, Ingoo Bae, Bongsung Park, Minsu Nam, Hojung Biotechnol Bioprocess Eng Review Paper As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Generally, AI is applied to fields with sufficient data such as computer vision and natural language processing, but there are many efforts to revolutionize the existing drug discovery process by applying AI. This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning. The main data sources in each field are also summarized in this review. In addition, an in-depth analysis of the remaining challenges and limitations will be provided, and proposals for promising future directions in each of the aforementioned areas. The Korean Society for Biotechnology and Bioengineering 2021-01-07 2020 /pmc/articles/PMC7790479/ /pubmed/33437151 http://dx.doi.org/10.1007/s12257-020-0049-y Text en © The Korean Society for Biotechnology and Bioengineering and Springer 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Paper
Kim, Hyunho
Kim, Eunyoung
Lee, Ingoo
Bae, Bongsung
Park, Minsu
Nam, Hojung
Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title_full Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title_fullStr Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title_full_unstemmed Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title_short Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
title_sort artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790479/
https://www.ncbi.nlm.nih.gov/pubmed/33437151
http://dx.doi.org/10.1007/s12257-020-0049-y
work_keys_str_mv AT kimhyunho artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches
AT kimeunyoung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches
AT leeingoo artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches
AT baebongsung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches
AT parkminsu artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches
AT namhojung artificialintelligenceindrugdiscoveryacomprehensivereviewofdatadrivenandmachinelearningapproaches